Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Alphabet’s Isomorphic Labs raises $600 million to advance AI drug design
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
eWeek3d
‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Fierce Biotech6d
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Alphabet-backed Isomorphic Labs bags $600 million funding to build next-gen AI drug design engine
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT developer OpenAI ...
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...
Alphabet Inc. (NASDAQ:GOOGL) Stock Holdings Increased by Lynx Investment Advisory
Lynx Investment Advisory increased its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 1.3% in the 4th quarter, ...
TechCrunch5d
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
with participation from GV and existing investor Alphabet, Google’s parent, it said. The funding will accelerate further development of Isomorphic’s AI drug design engine and support ...
Jim Cramer on Alphabet Inc. (GOOGL): “There’s No Good News”
We recently published a list of Jim Cramer Discusses These 8 Stocks & Says Trump’s Focused On His Goals And Not The Market.